|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | “En bloc ” caudate lobe and inferior vena cava resection following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal and liver metastasis of colorectal cancer显示文摘There are diverse protocols to manage patients with recurrent disease after primary cytoreductive surgery(CRS) with hyperthermic intraperitoneal chemotherapy(HIPEC) for peritoneal carcinomatosis. We describe a case of metachronous liver metastasis after CRS and HIPEC for colorectal cancer, successfully treated with a selective metastectomy and partial graft of the inferior vena cava. A 35-year-old female presented with a large tumour in the cecum and consequent colonic stenosis. After an emergency right colectomy, the patient received adjuvant chemotherapy. One year later she was diagnosed with peritoneal carcinomatosis, and it was decided to carry out a CRS/HIPEC. After 2 years of total remission, an isolated metachronous liver metastasis was detected by magnetic resonance imaging surveillance. The patient underwent a third procedure including a caudate lobe and partial inferior vena cava resection with a prosthetic graft interposition, achieving an R0 situation. The postoperative course was uneventful and the patient was discharged on postoperative day 17 after the liver resection. At 18-mo follow-up after the liver resection the patient remained free of recurrence. In selected patients, the option of re-operation due to recurrent disease should be discussed. Even liver resection of a metachronous metastasis and an extended vascular resection are acceptable after CRS/HIPEC and can be considered as a potential treatment option to remove all macroscopic lesions. | Patricia Sánchez-Velázquez Nicolas Moosmann Ingolf T?pel Pompiliu Piso | 2016 | World Journal of Gastroenterology2016，22，46： | 3 |
| 2 | Multimodality treatment strategies have changed prognosis of peritoneal metastases显示文摘For a long time, treatment of peritoneal metastases(PM) was mostly palliative and thus, this status was link with 'terminal status/despair'. The current multimodal treatment strategy, consisting of cytoreductive surgery(CRS) and hyperthermic intraperitoneal chemotherapy(HIPEC), has been strenuously achieved over time, but seems to be the best treatment option for PM patients. As we reviewed the literature data, we could emphasize some milestones and also, controversies in the history of proposed multimodal treatment and thus, outline the philosophy of this approach, which seems to be an unusual one indeed. Initially marked by nihilism and fear, but benefiting from a remarkable joint effort of human and material resources(multi-center and-institutional research), over a period of 30 years, CRS and HIPEC found their place in the treatment of PM. The next 4 years were dedicated to the refinement of the multimodal treatment, by launching research pathways. In selected patients, with requires training, it demonstrated a significant survival results(similar to the Hepatic Metastases treatment), with acceptable risks and costs. The main debates regarding CRS and HIPEC treatment were based on the oncologists' perspective and the small number of randomized clinical trials. It is important to statement the PM patient has the right to be informed of the existence of CRS and HIPEC, as a real treatment resource, the decision being made by multidisciplinary teams. | corneliu lungoci aurel ion mironiuc valentin muntean traian oniu hubert leebmann max mayr pompiliu piso | 2016 | World Journal of Gastrointestinal Oncology2016，8，1： | 2 |
| 3 | Results of combined gastrectomy and pancreatic resection in patients with advanced primary gastric carcinoma显示文摘 | Piso P Bellin T Aselmann H | 2002 | Dig Surg2002，19，4： | 1 |
| 4 | Total mesorectal excision for middle and lower rectal cancer: a single institution experience with 337 consecutive patients显示文摘 | Piso P Dahlke MH Mirena P | 2004 | J Surg Oncol2004，86，3： | 1 |
| 5 | Total mesorectal exci- sion for middle and lower rectal cancer: a single institution experience with 337 consecutive patients 显示文摘 | Piso P Dahlke MH Mirena P | 2004 | Surg Oncol2004，86，3： | 1 |
| 6 | Multimodality treatment of peritoneal carcinomatosis from colorectal cancer:first results of a new German centre for peritoneal surface malignancies显示文摘 | Piso P Dahlke MH Ghali N | 2010 | Int J Colcrectal Dis2010，22，： | 1 |
| 7 | Results of combined gastrectomy and pancreatic resection in patients with advanced primary gastric carcinoma显示文摘 | Piso P Bellin T Aselmann H | 2002 | Dig Surg2002，19，4： | 1 |
| 8 | Total mesorectal excision for middle and lower rectal cancer: a single institution experience with 337 consecutive patients 显示文摘 | Piso P Dahlke MH Mirena P | 2004 | Surg Oncol2004，86，3： | 1 |
| 9 | Applications of magnetic fluids for inertial sensors 显示文摘 | PISO M I | 1999 | Journal of Magnetism and Magnetic Materials1999，201，123： | 1 |
| 10 | Low transmission rate of 2009 H1N1 influenza during a long-distance bus trip显示文摘 | PISO R J ALBRECHT Y HANDSCHIN P | 2011 | Infection2011，39，： | 1 |
| 11 | Proximal Versus Distal Gastric Carcinoma—What Are the Differences?显示文摘 | Pompiliu Piso MD Uwe Werner MD Hauke Lang MD Petrit Mirena MD Jürgen Klempnauer MD | 2000 | Annals of Surgical Oncology2000，，7： | 1 |
| 12 | Current Status and Future Directions in Gastric Cancer with Peritoneal Dissemination显示文摘 | Gabriel Glockzin Pompiliu Piso | 2012 | Surgical Oncology Clinics of North America2012，，4： | 1 |
| 13 | Applications of magnetic fluids for inertial sensors 显示文摘 | PISO M I | 1999 | Journal of Magnetism and Magnetic Materials1999，201，2： | 1 |
| 14 | Total mesorectal excision for middle and lower rectal cancer:a single institution experience with 337 consecutive patients显示文摘 | Piso P Dahlke MH Mirena P | 2004 | J Surg Oncol2004，86，： | 1 |
| 15 | 显示文摘 | Piso M I Vekas L | 1998 | Adv Space Res1998，22，8： | 1 |
| 16 | Coverage of atypical pathogens for hospitalized patients with community-acquired pneu- monia is not guided by clinical parameters 显示文摘 | Piso RJ Amold C Bassetti S | 2013 | Swiss Med Wkly2013，10，4： | 1 |
| 17 | Differences in Attitude Toward Living and Postmortal Liver Donation in the United States, Germany, and Japan显示文摘 | Marc H. Dahlke Felix C. Popp Nadine Eggert Ludwig Hoy Hideaki Tanaka Katsunori Sasaki Pompiliu Piso Hans J. Schlitt | 2011 | Psychosomatics2011，，1： | 1 |
| 18 | Total mesorectal excision for middle and lower rectal cancer:a single institution experience with 337 consecutive patients显示文摘 | Piso P Dahlke MH Mirena P et a1 | 2004 | Surg Oncol2004，86，3： | 1 |
| 19 | Total mesorectal excision for middle and lower rectal cancer, a single institution experience with 337 consecutive patients显示文摘 | Piso P Dahlke MH | 2004 | J Surg Oncol2004，86，3： | 1 |
| 20 | Therapeutic potential of bone marrow stem ceils for liver diseases 显示文摘 | Popp FC Piso P Schlitt HJ | 2006 | Curr Stem Cell Res Ther2006，1，3： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员